426
Views
113
CrossRef citations to date
0
Altmetric
Future Perspectives

Personalized vaccines: the emerging field of vaccinomics

, MD, , PhD & , MD
Pages 1659-1667 | Published online: 10 Oct 2008

Bibliography

  • Black FL, Schiffman G, Pandey JP. HLA, Gm, and Km polymorphisms and immunity to infectious diseases in South Amerinds. Exp Clin Immunogenet 1995;12:206-16
  • Granoff DM, Pandey JP, Boies E, et al. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest 1984;74:1708-14
  • Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine 2008; In press
  • Poland GA, Jacobson RM. The genetic basis for variation in antibody response to vaccines. Curr Opin Pediatr 1998;10:208-15
  • Poland GA. Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response. Am J Hum Genet 1998;62(2):215-20
  • Poland GA, Ovsyannikova IG, Jacobson RM. Genetics and immune response to vaccines. In: Kaslow RA, McNicholl JM, Hill AVS (editors). Genetic susceptibility to infectious diseases. New York: Oxford University Press; 2008;414-29
  • Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 2007;82(6):653-64
  • Sinha P, Snyder JA, Kim EY, Moudgil KD. The major histocompatibility complex haplotypes dictate and the background genes fine-tune the dominant versus the cryptic response profile of a T-cell determinant within a native antigen: relevance to disease susceptibility and vaccination. Scand J Immunol 2007;65(2):158-65
  • Halassy B, Mateljak S, Bouche FB, et al. Immunogenicity of peptides of measles virus origin and influence of adjuvants. Vaccine 2006;24(2):185-94
  • Klein J, Sato A. The HLA system. First of two parts. N Engl J Med 2000;343:702-9
  • Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med 2000;343:782-6
  • Jin P, Wang E. Polymorphism in clinical immunology – from HLA typing to immunogenetic profiling. J Transl Med 2003;1(1):8
  • Burgner D, Jamieson SE, Blackwell JM. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect Dis 2006;6(10):653-63
  • Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998;51(6):593-604
  • Poland GA, Ovsyannikova IG, Jacobson RM, et al. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine 2001;20(3-4):430-8
  • Wang C, Tang J, Song W, et al. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004;39(4):978-88
  • Thio CL, Carrington M, Marti D, et al. Class II HLA alleles and Hepatitis B virus persistence in African Americans. J Infect Dis 1999;179:1004-6
  • Thursz M. Pros and cons of genetic association studies in hepatitis B. Hepatology 2004;40(2):284-6
  • Ovsyannikova IG, Jacobson RM, Vierkant RA, et al. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine 2004;22:1914-20
  • Ovsyannikova IG, Jacobson RM, Vierkant RA, et al. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis 2005;191(4):515-9
  • Ovsyannikova IG, Jacobson RM, Dhiman N, et al. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 2008;121:e1091-9
  • Ovsyannikova IG, Pankratz VS, Vierkant RA, et al. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis 2006;193(5):655-63
  • Ovsyannikova IG, Jacobson RM, Vierkant RA, et al. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine 2007;25(16):3090-100
  • Johnson KL, Ovsyannikova IG, Poland G, Muddiman DC. Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry. J Proteome Res 2005;4:2243-9
  • Ovsyannikova IG, Johnson KL, Muddiman DC, et al. Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides. J Virol 2004;78(1):42-51
  • Ota MO, Ndhlovu Z, Oh S, et al. Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. J Infect Dis 2007;195(12):1799-807
  • Sette A, Fikes J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr Opin Immunol 2003;15(4):461-70
  • Ovsyannikova IG, Johnson KL, Bergen HR III, Poland GA. Mass spectrometry and peptide-based vaccine development. Clin Pharmacol Ther 2007;82(6):644-52
  • Doolan DL, Southwood S, Chesnut R, et al. HLA-DR promiscuous T cell epitopes from Plasmodium falciparum ore-erythrocytic-state antigens restricted by multiple HLA class II alleles. J Immunol 2000;165:1123-37
  • Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci USA 2007;104(1):246-51
  • Deshpande A, Wheeler CM, Hunt WC, et al. Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer. J Infect Dis 2008;197(3):371-81
  • Gostout BS, Poland GA, Calhoun ES, et al. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 2003;88(3):326-32
  • Shrestha S, Wang C, Aissani B, et al. Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents. Cancer Epidemiol Biomarkers Prev 2007;16(8):1626-32
  • Collins A, Lonjou C, Morton NE. Genetic epidemiology of single-nucleotide polymorphisms. Proc Natl Acad Sci USA 1999;96(26):15173-7
  • Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409(6822):928-33
  • Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001;285(5):540-4
  • Spielberg SP. Therapeutics and toxicology. Curr Opin Pediatr 1998;10:201-2
  • Vandenbroeck K, Goris A. Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends Pharmacol Sci 2003;24(6):284-9
  • Kim M-J, Nafziger AN, Harro CD, et al. Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response. Vaccine 2003;21(11-12):1174-9
  • Lee HG, Lim J-S, Lee K-Y, et al. Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers. Virus Res 1997;50:185-94
  • Dhiman N, Cunningham JM, Jacobson RM, et al. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 2007;120(3):666-72
  • Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Ann Rev Genomics Hum Genet 2002;3:263-92
  • Fitzgerald KA, Golenbock DT. Immunology. The shape of things to come. Science 2007;316(5831):1574-6
  • Mata-Haro V, Cekic C, Martin M, et al. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007;316(5831):1628-32
  • Dhiman N, Ovsyannikova IG, Vierkant RA, et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008;26:1731-6
  • Perera LP, Waldmann TA, Mosca JD, et al. Development of smallpox vaccine candidates with integrated IL-15 that demonstrate superior immunogenicity, efficacy and safety in mice. J Virol 2007; Online
  • Keen LJ. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 2002;10(2-3):143-6
  • Relman DA. Learning to appreciate our differences. J Infect Dis 2008;198(1):4-5
  • Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008;47(3):401-9
  • Rock MT, Yoder SM, Talbot TR, et al. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J Infect Dis 2004;189(8):1401-10
  • Crowe JE Jr. Genetic predisposition for adverse events after vaccination. J Infect Dis 2007;196(2):176-7
  • Slifka MK. The Future of Smallpox Vaccination: is MVA the key? Med Immunol 2005;4(1):2
  • Poland GA, Grabenstein JD, Neff JM. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine 2005;23:2078-81
  • Henderson DA, Moss B. Smallpox and vaccinia In: Plotkin SA, Orenstein WA, editors, Vaccines. 3rd edition. WB Saunders Company, Philadelphia, PA; 1999. p. 74-97
  • Halsell JS, Riddle JR, Atwood JE, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003;289:3283-9
  • Arness MK, Eckart RE, Love SS, et al. Myopericarditis following smallpox vaccination. Am J Epidemiol 2004;160(7):642-51
  • Wilson CB, Marcuse EK. Vaccine safety – vaccine benefits: science and the public's perception. Nat Rev Immunol 2001;1(2):160-5
  • McKinney BA, Reif DM, Rock MT, et al. Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis 2006;194(4):444-53
  • Stanley SL Jr, Frey SE, Taillon-Miller P, et al. The immunogenetics of smallpox vaccination. J Infect Dis 2007;196(2):212-9
  • Reif DM, McKinney BA, Motsinger AA, et al. Genetic basis for adverse events after smallpox vaccination. J Infect Dis 2008;198:1-7
  • Usonis V, Bakasenas V, Kaufhold A, et al. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. Pediatr Infect Dis J 1999;18(1):42-8
  • Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA 2004;292(3):351-7
  • Klein SL. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000;24(6):627-38
  • Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008;8(9):737-44
  • Green MS, Shohat T, Lerman Y, et al. Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol 1994;23:1078-81
  • Mitchell LA, Zhang T, Tingle AJ. Differential antibody responses to rubella virus infection in males and females. J Infect Dis 1992;166:1258-65
  • Ovsyannikova IG, Jacobson RM, Vierkant RA, et al. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004;65:1506-15
  • Ovsyannikova IG, Jacobson RM, Targonski PV, et al. Racial and gender disparities in immune responses to smallpox vaccine in healthy adults [abstract]. 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 2007 Sept 17 – 20; Chicago, Ill
  • Standards for child and adolescent immunization practices. National Vaccine Advisory Committee. Pediatrics 2003;112(4):958-63
  • Wallinga J, Heijne JC, Kretzschmar M. A measles epidemic threshold in a highly vaccinated population. PLoS Med 2005;2(11):e316
  • Huerta M, Davidovitch N, Aboudy Y, et al. Declining population immunity to mumps among Israeli military recruits. Vaccine 2006;24(37-39):6300-3
  • Marin M, Guris D, Chaves SS, et al. Prevention of Varicella. Recommendations of the Advisory Committe on Immunization Practices. MMWR 2007;56(RR04):1-40
  • Siber GR, Santosham M, Reid GR, et al. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. N Engl J Med 1990;323:1387-92
  • Santosham M, Rivin B, Wolff M, et al. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. J Infect Dis 1992;165(Suppl 1):S144-51
  • Poland GA. Pharmacology, vaccinomics, and the 2nd golden age of vaccinology. Clin Pharmacol Ther 2007;82(6):623-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.